风湿性心脏病

fēnɡ shī xìnɡ xīn zànɡ bìnɡ
  • Rheumatic heart disease;rheumatism of heart
风湿性心脏病风湿性心脏病
  1. 前列腺素E1在风湿性心脏病并肺动脉高压围手术期应用

    The perioperative application of prostaglandin E_1 for patients with rheumatic heart diease associated with pulmonary hypertension

  2. 风湿性心脏病心肌组织中fas基因表达与心肌病理变化的关系

    Relationship between expression of fas gene and cardiac pathology in rheumatic heart disease

  3. 风湿性心脏病患者心房组织Ⅰ、Ⅲ型胶原mRNA表达及相关因素研究

    The Study of Express and Correlate Factor of Tape ⅰ and ⅲ Precollagen mRNA in Human Atria of Rheumatic Heart Disease

  4. B组风湿性心脏病的比例为13%,较A组的27%有所下降;

    The percentage of rheumatic heart diseases as underlying diseases ( 13 % ) in group B was lower than that in group A ( 27 % ) .

  5. ATP对风湿性心脏病肺动脉高压患者血流动力学影响的研究

    Effect of ATP upon haemodynamics of patients with rheumatic heart disease complicated with pulmonary artery hypertension

  6. 但ATP对风湿性心脏病围术期肺高压的治疗效果还不明确。

    But the treatment result of ATP in postoperative pulmonary hypertension secondary to rheumatic heart disease is not clear .

  7. 汉族人群Toll样受体5、9基因单核苷酸多态性与风湿性心脏病的相关性研究

    Association Analysis of Single-nucleotide Polymorphisms in Toll-like Receptor 5 and 9 Genes with Rheumatic Heart Disease in Chinese Han Population

  8. 目的研究促凋亡基因fas在风湿性心脏病心肌组织中的表达与心肌病理变化的关系及意义。

    AIM To study the relationship between expression of fas gene and cardiac pathological changes in rheumatic heart disease .

  9. 以二尖瓣狭窄为主的风湿性心脏病(RHD)患者主要表现为右室扩大。

    The patients with rheumatic heart disease mainly showed right ventricle enlargement .

  10. 风湿性心脏病心房颤动伴长RR间期的心内电生理研究

    Intracardiac electrophysiologic evaluation of atrial fibrillation associated with long RR interval in rheumatic heart diseases

  11. 结果显示风湿性心脏病二尖瓣和主动脉瓣的胶原含量明显高于尸检对照组(P<0.001),胶原Ⅰ/Ⅲ比值也明显升高(P<0.001)。

    The results showed that collagen content in MV and AV significantly increased in patients with RHD ( P < 0.001 ), collagen type ⅰ / ⅲ ratio also increased ( P < 0.001 ) .

  12. 结论发生IE的基础心脏病中,先天性心脏病跃居首位,风湿性心脏病逐渐减少。

    Conclusion Congenital cardiovascular diseases is in the first place in the basic heart diseases , and rheumatic heart disease is decreasing gradually .

  13. 非风湿性心脏病Af患者复律即刻左房射血力(LAF)明显低于正常对照组;

    The left atrial ejection force ( LAF ) immediately postcardioversion decreased significantly in non-rheumatic heart disease .

  14. 目的观察风湿性心脏病(RHD)心房纤颤(AF)患者心房肌细胞内是否存在Ca2+超载。

    AIM To observe whether Ca 2 + overload exists in atrial myocytes of rheumatic heart disease patients with atrial fibrillation .

  15. 目的:观察风湿性心脏病(风心病)重度肺动脉高压患者体外循环(CPB)前、后肺血流动力学变化规律。

    Objective : To observe the pulmonary hemodynamic alterations before and after cardiopulmonary bypass ( CPB ) in valvular heart diseases with pulmonary hypertension .

  16. 目的研究体外循环(CPB)对风湿性心脏病患者心肌β受体系统的影响。

    Objective To study the effects of cardiopulmonary bypass ( CPB ) on human cardiac beta adrenergic receptor system in rheumatic heart disease patients .

  17. 结论在风湿性心脏病伴肾功能不全行心脏手术患者体外循环中全程超滤可降低BUN,除去体内过多的水分,减少术后并发症的发生。

    Conclusion Ultrafiltration can decrease BUN and remove water during CPB for patients with severe cardiac valve disease , and lower the postoperative complications .

  18. 方法:采用国产单球囊导管对4例风湿性心脏病二尖瓣狭窄患者进行PBMV。

    Method : 4 cases of rheumatic mitral stenosis were treated by PBMV with single balloon catheter .

  19. 方法:对风湿性心脏病二尖瓣狭窄患者43例,在食道四腔心平面观察PBMV过程。结果:TEE结合X线,引导了全部患者的球囊扩张过程和20例患者的穿刺房间隔过程。

    Methods : Forty three patients with rheumatic mitral stenosis underwent PBMV with intraoperative TEE monitoring on the four chamber view .

  20. 结果风湿性心脏病患者HRA阳性率53.8%(28/52);

    Results HRA positive rate of rheumatic heart disease patients was 53 . 8 % ( 28 / 52 );

  21. 但活动期风湿性心脏病(简称风心病)组病人的抗DNA酶B阳性率(82.6%)明显超过ASO阳性率(55.4%)(P<0.001);

    However , the positive rate of anti DNase B ( 82.6 % ) was significantly higher than that of ASO ( 55.4 % ) in acute rheumatic heart disease ( ARHD ) group ( P < 0.001 ) .

  22. 本文比较了83例不同心功能分级的风湿性心脏病、高血压性心脏病和冠状动脉粥样硬化性心脏病所致慢性左心功能不全患者红细胞超氧物歧化酶(SOD)的活性大小。

    The activity of erythrocyte superoxide dismutase ( SOD ) was observed in 83 patients with chronic left cardiac insufficiency subsequent to rheumatic , hypertensive or coronary atherosclerotic heart dis - ease at various grades of cardiac function .

  23. 目的:探讨利用先天性心脏病(CHD)及风湿性心脏病(RHD)患者心包组织制作自体心包生物瓣膜的可行性。

    Objective : To investigate the feasible of making autologous pericardial heart valves by autologous pericardium of patients with congenital heart disease ( CHD ) and rheumatic heart disease ( RHD ) .

  24. 方法:用酶联免疫法检测风湿性心脏病患者血浆颗粒膜蛋白-140(GMP-140)含量。

    Methods : The plasma Concentration of granule membrance protein 140 ( GMP - 140 ) in patients with rheumatic heart disease was detected by ELISA method .

  25. 目的:研究50例风湿性心脏病二尖瓣狭窄(风心二狭)患者PBMV治疗前后血浆NO、ET及血流动力学变化。

    Objective : To observe the changes of the plasmic nitric oxide ( NO ), endothelin ( ET ) and hemodynamics before and after PBMV of 50 patients with rheumatic mitral stenosis .

  26. 应用漂浮导管监测前列腺素E1(PGE1)对11例以二尖瓣狭窄为主的风湿性心脏病合并肺动脉高压患者的体循环和肺循环的血液动力学作用。

    The hemodynamic effects of prostaglandin E1 ( PGE1 ) on pulmonary and systemic circulations were studied in 11 patients with rheumatic mitral disease complicated by pulmonary hypertension .

  27. 结果:风湿性心脏病患者血浆中s-ICAM-1,s-VCAM-1,vWF浓度都高于健康人群(P0.01);

    Results s-ICAM-1 , s-VCAM-1 and vWF levels were significantly elevated in patients with RHD compared with healthy people ( P0.01 ) .

  28. 应用经胸及经食道超声心动图(TTE,TEE)技术评价风湿性心脏病二尖瓣狭窄患者左心耳功能。

    Objective : To evaluate the left atrium appendage ( LAA ) function in rheumatic mitral stenosis ( MS ) by transthoracic and transesophageal echocardiography ( TTE , TEE ) .

  29. 方法:选择风湿性心脏病二尖瓣狭窄患者103例,均进行CT增强扫描、食道超声心动图和体表二维超声心动图检查,以检验有无左心房内附壁血栓形成。

    Methods : We selected 103 patients who suffered from rheumatic mitral stenosis , each of whom was examined with CT enhanced scanning , esophageal echocardiography and body surface two dimensional echocardiography in order to test whether there were thrombi adhering to the endocardium of the left atrium .

  30. 为观察大剂量抗坏血酸对纤溶系统活性的影响,测定了健康家兔和风湿性心脏病病人的ELT。

    The ELT ( euglobulin lysis time ) of healthy rabbits and visceral rheumatism patients was measured in order to find out the effect of ascorbic acid on fibrinolysis system .